Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0599766 (
functional recovery
)
13,441
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Plasticity Related Gene family covers five, brain-specific, transmembrane proteins (PRG1-5, also termed LPPR1-5) that operate in neuronal plasticity during development, aging and brain trauma. Here we investigated the role of the PRG family on axonal and filopodia outgrowth. Comparative analysis revealed the strongest outgrowth induced by
PRG3
(LPPR1). During development,
PRG3
is ubiquitously located at the tip of neuronal processes and at the plasma membrane and declines with age. In utero electroporation of
PRG3
induced dendritic protrusions and accelerated spine formations in cortical pyramidal neurons. The neurite growth promoting activity of
PRG3
requires RasGRF1 (RasGEF1/Cdc25) mediated downstream signaling. Moreover, in axon collapse assays,
PRG3
-induced neurites resisted growth inhibitors such as myelin, Nogo-A (Reticulon/RTN-4), thrombin and LPA and impeded the RhoA-Rock-PIP5K induced neurite repulsion. Transgenic adult mice with constitutive
PRG3
expression displayed strong axonal sprouting distal to a spinal cord lesion. Moreover, fostered
PRG3
expression promoted complex motor-behavioral recovery compared to wild type controls as revealed in the Schnell swim test (SST). Thus,
PRG3
emerges as a developmental RasGRF1-dependent conductor of filopodia formation and axonal growth enhancer.
PRG3
-induced neurites resist brain injury-associated outgrowth inhibitors and contribute to
functional recovery
after spinal cord lesions. Here, we provide evidence that
PRG3
operates as an essential neuronal growth promoter in the nervous system. Maintaining
PRG3
expression in aging brain may turn back the developmental clock for neuronal regeneration and plasticity.
...
PMID:Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury. 2774 21